Breaking: Advisory panel recommends J&J vaccine pause should end

The benefits of the Johnson & Johnson COVID-19 vaccine outweigh the risks — and its use should... If you are having trouble viewing this email, click here.

APR 23, 2021   Advisory panel recommends Johnson & Johnson vaccine pause should end   The benefits of the Johnson & Johnson COVID-19 vaccine outweigh the risks — and its use should be resumed for anyone over the age of 18 with no warnings added, an influential, independent advisory panel ruled Friday Read More     Advertisement       The email address for your subscription is moroccaninuae.note@blogger.com Manage Email Preferences or Unsubscribe   For more New York Post, download the New York Post App:

Follow us on: New York Post 1211 Avenue of the Americas New York, NY 10036 USA © Copyright 2021 NYP Holdings, Inc. All rights reserved Privacy  |  Terms of Use  |  Your Ad Choices